Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-007070
Filing Date
2025-01-29
Accepted
2025-01-29 10:07:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12591
2 EXHIBIT 99.1 tm254005d11_ex99-1.htm EX-99.1 8198
3 EXHIBIT 99.2 tm254005d11_ex99-2.htm EX-99.2 5066
  Complete submission text file 0001104659-25-007070.txt   27479
Mailing Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201
Business Address 1603 ORRINGTON AVE. 13TH FLOOR EVANSTON IL 60201 (847)905-4400
Magnetar Financial LLC (Filed by) CIK: 0001352851 (see all company filings)

EIN.: 043818748 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 52 E 83RD ST. NEW YORK NY 10028
Business Address 52 E 83RD ST. NEW YORK NY 10028 (413) 204-2769
Translational Development Acquisition Corp. (Subject) CIK: 0001926599 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94817 | Film No.: 25567134
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)